DiaSorin S.p.A. 2024 Q3 - Results - Earnings Call Presentation
…
99,950€
0,59%
Echtzeit-Aktienkurs DiaSorin S.p.A.
Bid:
Ask:
Nachrichten zur DiaSorin S.p.A. Aktie
DiaSorin S.p.A. (DSRLF) Q2 2024 Earnings Call Transcript
…
DiaSorin S.p.A. (DSRLF) Q4 2023 Earnings Call Transcript
…
DiaSorin S.p.A. 2023 Q4 - Results - Earnings Call Presentation
…
Blood Transfusion Diagnostics Market revenue to reach USD 9 Billion by 2033, says Research Nester
Key blood transfusion diagnostics market players include Immucor, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Quotient Limited, Beckman Coulter, Inc., DiaSorin…
Immunoprotein Diagnostic Testing Market revenue to hit USD 234 Billion by 2036, says Research Nester
Leading immunoprotein diagnostic testing market players include Thermofisher Scientific Inc., Abbott Laboratories, Abcam plc, Bio-Rad Laboratories, Inc., Danaher Corporation, DiaSorin…
Blood Screening Market revenue to hit USD 5.03 Billion by 2035, says Research Nester
Key blood screening market players include Abbott Laboratories, Grifols, S.A., Quotient Limited, Thermo Fisher Scientific Inc., BD, Ortho al Diagnostics,…
DiaSorin S.p.A. (DSRLF) Q3 2023 Earnings Call Transcript
…
Global Flow Cytometry Market Size To Grow USD 11.8 Billion by 2032 | CAGR of 9.6%
The Global Flow Cytometry Market Size was valued at USD 4.7 Billion in 2022 and The Worldwide Flow Cytometry Market…
DiaSorin S.p.A. reports 1H results
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed
SALUGGIA, Italy, and FREMONT, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc.…
Cytek Biosciences to acquire flow cytometry & imaging business from DiaSorin
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
SALUGGIA, Italy and FREMONT, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) -- DiaSorin (FTSE MIB: DIA) and Cytek Biosciences,…
Global Peptic Ulcer Testing Strategic Business Report 2023: Featuring Biomerica, bioMerieux, Bio-Rad Laboratories and DiaSorin Among Others
DUBLIN, Feb. 13, 2023 /PRNewswire/ -- Research and Markets The "Peptic Ulcer Testing: Global Strategic Business Report" report has been…
Global Enteric Disease Testing Market Report to 2027 - Players Include Cepheid, Coris BioConcept, DiaSorin, Meridian Bioscience and Quest Diagnostics
DUBLIN, Feb. 2, 2023 /PRNewswire/ -- The "Enteric Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast…